Saturday 17 October 2026
Export OM’s income statement to Excel — free account
Outset Medical, Inc.
Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 6.73%, free cash flow fell 90.5% and total debt rose 4.20%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
3.94
0.14
−3.43%
Follow OM
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 5 | 3 | 3 | 5 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(5.37) | (5.41) | (3.92) | 2.01 | 12.44 | 5.79 | — | — | — |
P/S ratio |
0.47 | 0.51 | 2.14 | 10.40 | 20.49 | 18.63 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(9.87) | (10.47) | (8.02) | (2.18) | 3.17 | 3.67 | (14.26) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
(3.25) | (3.00) | (3.25) | (3.50) | (3.18) | — | — | — | — |
P/Operating CF |
(5.93) | (3.50) | (11.44) | (34.77) | (64.34) | (36.00) | (18.32) | (18.32) | — |
P/B ratio |
0.44 | 2.15 | 2.28 | 4.88 | 5.62 | 2.83 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.44 | 2.15 | 2.28 | 4.88 | 5.62 | 2.83 | 0.00 | 0.00 | — |
EV/Sales |
(0.13) | 0.86 | 1.59 | 8.75 | 17.48 | 12.94 | 0.00 | 0.00 | — |
EV/EBITDA |
0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
0.33 | (0.84) | (1.58) | (6.93) | (13.77) | (6.52) | (2.14) | (2.14) | — |
EV/FCF |
0.32 | (0.83) | (1.54) | (6.55) | (13.45) | (5.98) | (2.00) | (2.00) | — |
Quick Ratio |
5.24 | 4.28 | 4.27 | 6.07 | 7.06 | 8.76 | 2.97 | 14.09 | — |
Current Ratio |
6.67 | 5.69 | 5.26 | 7.19 | 7.93 | 9.43 | 3.20 | 14.46 | — |
Net Debt/EBITDA |
1.13 | (0.34) | 0.43 | 1.23 | 2.51 | 2.50 | 0.59 | 2.46 | — |
Debt/Assets |
36.39% | 71.57% | 41.46% | 24.08% | 6.42% | 7.35% | 32.89% | 0.00% | 0.00% |
Debt/Equity |
0.76 | 7.36 | 1.06 | 0.39 | 0.08 | 0.09 | 0.78 | 0.00 | — |
Asset Turnover |
0.44 | 0.39 | 0.37 | 0.27 | 0.24 | 0.20 | 0.34 | 0.00 | — |
Operating CF/Net income |
0.57 | 0.91 | 0.76 | 0.89 | 0.99 | 1.25 | 0.82 | 0.64 | — |
Capex/Depreciation |
(0.38) | (0.90) | 6.15 | (1.48) | (0.44) | (2.83) | (6.57) | (6.09) | — |
Interest Coverage |
(4.78) | (4.75) | (13.39) | (45.15) | (76.10) | (40.63) | (16.52) | (10.04) | — |
| (106.20%) | (170.97%) | (93.69%) | (52.56%) | (37.55%) | 364.06% | 25.89% | 22.14% | — | |
| (30.23%) | (43.41%) | (48.41%) | (37.74%) | (30.42%) | (32.23%) | (193.43%) | 0.00% | — | |
ROIC |
(76.86%) | (108.17%) | (213.60%) | (183.56%) | (126.76%) | (169.11%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(37.47%) | (57.91%) | (69.35%) | (48.27%) | (35.56%) | (24.47%) | (136.45%) | (52.07%) | — |
Average Days of Receivables |
86.55 | 114.36 | 92.33 | 88.80 | 91.07 | 47.28 | 94.75 | 197.87 | — |
Research and Development Expense of Revenue |
17.77% | 33.77% | 43.96% | 42.34% | 35.81% | 57.78% | 154.71% | 1,141.80% | — |
Selling, General and Administrative Expense of Revenue |
77.19% | 99.87% | 108.50% | 112.67% | 98.81% | 151.36% | 193.51% | 873.54% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
13.07% | 25.82% | 29.63% | 23.58% | 17.00% | 42.93% | 5.86% | 39.26% | — |
Graham Net Nets |
2.01 | 0.16 | 0.36 | 0.18 | 0.15 | 0.29 | 0.46 | 0.46 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(183.02%) | (223.31%) | (62.02%) | (13.69%) | (6.25%) | (23.70%) | (31.41%) | (31.41%) | — |
Free Cash Flow Yield |
(83.51%) | (203.29%) | (48.22%) | (12.84%) | (6.34%) | (11.62%) | (34.92%) | (34.92%) | — |
Revenue per Share |
7.85 | 32.83 | 39.45 | 35.92 | 33.74 | 45.77 | 263.60 | 41.47 | — |
Operating CF per Share |
(3.05) | (33.58) | (39.75) | (45.37) | (42.84) | (90.75) | (1,228.88) | (959.55) | — |
Capex per Share |
(0.05) | (0.26) | (1.04) | (2.59) | (1.02) | (8.32) | (57.57) | (36.49) | — |
Free Cash Flow per Share |
(3.10) | (33.85) | (40.79) | (47.96) | (43.86) | (99.07) | (1,286.45) | (996.03) | — |
Cash per Share |
11.11 | 45.82 | 61.52 | 89.50 | 111.64 | 288.58 | 1,225.14 | 2,950.04 | — |
Shareholders Equity per Share |
8.35 | 7.74 | 37.18 | 76.58 | 123.02 | 301.17 | 651.38 | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
8.35 | 7.74 | 37.18 | 76.58 | 123.02 | 301.17 | 651.38 | 0.00 | — |
Free Cash Flow |
(47.12) | (117.21) | (134.81) | (154.05) | (133.37) | (108.09) | (73.58) | (48.21) | — |
Working Capital |
213.25 | 212.84 | 235.90 | 321.70 | 358.11 | 309.22 | 54.74 | 137.43 | — |
Capital Expenditures |
(0.80) | (0.91) | (3.44) | (8.32) | (3.11) | (9.08) | (3.29) | (1.77) | — |
Net Current Asset Value |
113.34 | 9.25 | 100.30 | 219.52 | 320.42 | 270.69 | 28.54 | 147.65 | — |
EV/EBIT |
0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.01 | 0.01 | 0.03 | 0.07 | 0.03 | 0.18 | 0.22 | 0.88 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.45 | 0.12 | (0.04) | 0.35 | 0.55 | 0.21 | 0.06 | 0.10 | — |
Cash ROIC |
(12.02%) | (30.61%) | (29.54%) | (24.46%) | (17.94%) | (16.06%) | (53.95%) | (28.08%) | — |
Accounts Receivable Turnover |
3.74 | 3.31 | 4.27 | 4.30 | 6.40 | 9.62 | 6.03 | 0.80 | — |
Accounts Payable Turnover |
32.94 | 15.51 | 31.53 | 82.45 | 28.31 | 12.71 | 7.89 | 1.95 | — |
Inventory Turnover |
1.36 | 1.38 | 2.01 | 2.15 | 3.30 | 5.48 | 8.63 | 2.13 | — |
Average Days of Payables |
2.78 | 18.76 | 20.98 | 2.26 | 6.77 | 28.68 | 55.06 | 151.58 | — |
Days of Inventory on Hand |
238.96 | 288.54 | 177.20 | 192.62 | 150.56 | 106.56 | 51.02 | 135.81 | — |
Average Receivables |
31.97 | 34.30 | 30.53 | 26.84 | 16.03 | 5.19 | 2.50 | 2.50 | — |
Average Payables |
2.21 | 4.84 | 3.22 | 1.18 | 3.36 | 4.95 | 4.17 | 4.17 | — |
Average Inventory |
53.50 | 54.30 | 50.35 | 45.33 | 28.78 | 11.49 | 3.81 | 3.81 | — |
Average Assets |
270.15 | 294.80 | 356.96 | 431.79 | 433.65 | 246.10 | 44.18 | 0.00 | — |
Average Common Equity |
76.89 | 74.85 | 184.44 | 310.04 | 351.35 | (21.79) | (330.07) | (330.07) | — |
Columns are period end dates